8-27765231-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001304532.2(CCDC25):c.-104A>G variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000204 in 1,502,306 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001304532.2 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC25 | NM_018246.3 | c.49A>G | p.Ile17Val | missense_variant | 2/9 | ENST00000356537.9 | NP_060716.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC25 | ENST00000356537.9 | c.49A>G | p.Ile17Val | missense_variant | 2/9 | 1 | NM_018246.3 | ENSP00000348933.4 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152206Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000120 AC: 23AN: 192348Hom.: 0 AF XY: 0.000115 AC XY: 12AN XY: 104056
GnomAD4 exome AF: 0.000208 AC: 281AN: 1350100Hom.: 0 Cov.: 28 AF XY: 0.000198 AC XY: 132AN XY: 666326
GnomAD4 genome AF: 0.000164 AC: 25AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2024 | The c.49A>G (p.I17V) alteration is located in exon 2 (coding exon 2) of the CCDC25 gene. This alteration results from a A to G substitution at nucleotide position 49, causing the isoleucine (I) at amino acid position 17 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at